The cross-trade association EMIR Reporting Best Practices were initially developed and published in March 2020, covering both over-the-counter and exchange-traded derivatives. These best practices were developed to improve the accuracy and efficiency of trade reporting and to reduce compliance costs, and are available to all market participants to access and implement.
A review of the best practices was carried out by member firms in 2021, and subsequently 23 fields have either been updated or new best practices put in place. Additionally, the EU-EMIR and UK-EMIR reporting fields – along with their related best practices – have been set out on separated tabs.
The EMIR Reporting Best Practices is a cross-trade association initiative developed jointly by the European Fund and Asset Management Association (EFAMA), European Venues and Intermediaries Association (EVIA), Futures Industry Association (FIA), German Investment Funds Association (BVI), Global Foreign Exchange Division (GFXD), International Swaps and Derivatives Association, Inc. (ISDA) and Investment Association (IA).
Documents (1) for EMIR Reporting Best Practices
Latest
Cross-product Netting Under US Capital Rules
ISDA, FIA and the Securities Industry and Financial Markets Association (SIFMA) have developed a discussion paper to: (i) provide an overview of cross-margining programs developed by clearing organizations and their importance in the context of implementing recent market reforms with...
ISDA/IIB/SIFMA request to extend 22-14
This joint ISDA/IIB/SIFMA letter requests reporting relief for certain non-US swap dealers in Australia, Canada, the European Union, Japan, Switzerland or the United Kingdom with respect to their swaps with non-US persons. The joint trade association letter, submitted to CFTC...
ISDA In Review – March 2025
A compendium of links to new documents, research papers, press releases and comment letters published by ISDA in March 2025.
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.